Director/PDMR Shareholding

Smith & Nephew Plc

03 June 2026

 

SMITH & NEPHEW PLC

3 June 2026

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2025 final dividend payment on 27 May 2026.
Date of Transaction	2026 - 05 - 27
Place of Transaction	London Stock Exchange (XLON)

Name (Position)	Director / PDMR	Price	Volume	Aggregated information
Deepak Nath (Chief Executive Officer)	Director	11.38002	6,259.14583	N/A Single Transaction
John Rogers (Chief Financial Officer)	Director	11.38002	61.89914	N/A Single Transaction
Paul Connolly (President, Global Operations)	PDMR	11.38002	1190.0452	N/A Single Transaction
Alison Parkes (Chief Compliance Officer)	PDMR	11.38002	153.58792	N/A Single Transaction
Scott Schaffner (President, Sports Medicine)	PDMR	11.38002	2148.33828	N/A Single Transaction

Philip Horner

Deputy Company Secretary

Smith & Nephew plc

Tel:  [phone]

 

END